Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 1
1954 1
1955 1
1959 1
1961 1
1964 2
1965 1
1966 2
1967 1
1968 1
1969 4
1971 1
1972 2
1973 2
1974 6
1975 3
1977 1
1978 3
1979 2
1980 1
1981 4
1982 4
1983 2
1984 5
1985 5
1986 1
1987 2
1988 1
1989 1
1990 6
1991 2
1992 12
1993 6
1994 8
1995 6
1996 3
1997 6
1998 8
1999 3
2000 12
2001 11
2002 8
2003 7
2004 13
2005 16
2006 29
2007 30
2008 34
2009 45
2010 35
2011 35
2012 51
2013 63
2014 65
2015 88
2016 91
2017 87
2018 73
2019 92
2020 102
2021 72
Text availability
Article attribute
Article type
Publication date

Search Results

1,030 results
Results by year
Filters applied: . Clear all
Page 1
Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H, Oura S, Holmes B, Tanaka M, Seki M, Hirano H, Aburatani H, Ishitani R, Ikawa M, Yachie N, Zhang F, Nureki O. Nishimasu H, et al. Among authors: okazaki s. Science. 2018 Sep 21;361(6408):1259-1262. doi: 10.1126/science.aas9129. Epub 2018 Aug 30. Science. 2018. PMID: 30166441 Free PMC article.
Structure of the miniature type V-F CRISPR-Cas effector enzyme.
Takeda SN, Nakagawa R, Okazaki S, Hirano H, Kobayashi K, Kusakizako T, Nishizawa T, Yamashita K, Nishimasu H, Nureki O. Takeda SN, et al. Among authors: okazaki s. Mol Cell. 2021 Feb 4;81(3):558-570.e3. doi: 10.1016/j.molcel.2020.11.035. Epub 2020 Dec 16. Mol Cell. 2021. PMID: 33333018
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis.
Nakatani S, Ohara T, Ashihara K, Izumi C, Iwanaga S, Eishi K, Okita Y, Daimon M, Kimura T, Toyoda K, Nakase H, Nakano K, Higashi M, Mitsutake K, Murakami T, Yasukochi S, Okazaki S, Sakamoto H, Tanaka H, Nakagawa I, Nomura R, Fujiu K, Miura T, Morizane T; Japanese Circulation Society Joint Working Group. Nakatani S, et al. Among authors: okazaki s. Circ J. 2019 Jul 25;83(8):1767-1809. doi: 10.1253/circj.CJ-19-0549. Epub 2019 Jul 5. Circ J. 2019. PMID: 31281136 Free article. No abstract available.
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, Okazaki S, Yamashita S, Miura S, Miki H, Matsuda H, Koike M, Izuhara M, Araki T, Tsuchie K, Azis IA, Arauchi R, Abdullah RA, Oh-Nishi A, Horiguchi J. Miyaoka T, et al. Among authors: okazaki s. Clin Neuropharmacol. 2018 Sep/Oct;41(5):151-155. doi: 10.1097/WNF.0000000000000299. Clin Neuropharmacol. 2018. PMID: 30234616 Clinical Trial.
De novo variants in CAMK2A and CAMK2B cause neurodevelopmental disorders.
Akita T, Aoto K, Kato M, Shiina M, Mutoh H, Nakashima M, Kuki I, Okazaki S, Magara S, Shiihara T, Yokochi K, Aiba K, Tohyama J, Ohba C, Miyatake S, Miyake N, Ogata K, Fukuda A, Matsumoto N, Saitsu H. Akita T, et al. Among authors: okazaki s. Ann Clin Transl Neurol. 2018 Jan 29;5(3):280-296. doi: 10.1002/acn3.528. eCollection 2018 Mar. Ann Clin Transl Neurol. 2018. PMID: 29560374 Free PMC article.
How effectors promote beneficial interactions.
Miwa H, Okazaki S. Miwa H, et al. Among authors: okazaki s. Curr Opin Plant Biol. 2017 Aug;38:148-154. doi: 10.1016/j.pbi.2017.05.011. Epub 2017 Jun 13. Curr Opin Plant Biol. 2017. PMID: 28622658 Review.
Crystal structure of heliorhodopsin.
Shihoya W, Inoue K, Singh M, Konno M, Hososhima S, Yamashita K, Ikeda K, Higuchi A, Izume T, Okazaki S, Hashimoto M, Mizutori R, Tomida S, Yamauchi Y, Abe-Yoshizumi R, Katayama K, Tsunoda SP, Shibata M, Furutani Y, Pushkarev A, Béjà O, Uchihashi T, Kandori H, Nureki O. Shihoya W, et al. Among authors: okazaki s. Nature. 2019 Oct;574(7776):132-136. doi: 10.1038/s41586-019-1604-6. Epub 2019 Sep 25. Nature. 2019. PMID: 31554965
1,030 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page